O'Neill Institute  |  September 5, 2019

Read the Publication

Hepatitis C (HCV) cases have increased three-and-a- half times from 2010-2016, primarily due to the increase in injection drug use as the United States grapples with the public health crisis of substance use disorder (SUD). Syringe services programs provide a broad range of harm reduction services and can improve the health of persons who inject drugs including reducing HCV transmission.

Read the Big Ideas here.

Related Projects

Hepatitis Policy Project

Latest publications See All

Journal Article

October 24, 2024

Alana Sharp Matthew M. Kavanagh Ndivhuwo Rambau, Soeurette Policar, Elise Lankiewicz, Allan Nsubuga, Luke Chimhanda, Anele Yawa, Kenneth Mwehonge, Donald Denis Tobaiwa, Gérald Marie Alfred, Asia Russell, Solange Baptiste, Onesmus Mlewa Kalama, Rodelyn M. Marte, Naïké Ledan, Brian Honermann, Krista Lauer, Nadia Rafif, Susan Perez, Gang Sun, Anna Grimsrud, Laurel Sprague, Keith Mienies